Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fanelli

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Diabetes|July 27, 2001
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemiaS A Segel, C G Fanelli, C S Dence, et al.
Diabetes/Metabolism Research and Reviews|March 3, 2020
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach StudyRiccardo C Bonadonna, Andrea Giaccari, Raffaella Buzzetti, et al.
Diabetes Care|October 23, 2012
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetesPaola Lucidi, Francesca Porcellati, Paolo Rossetti, et al.
Diabetes Care|April 19, 2011
Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over studyPaola Lucidi, Francesca Porcellati, Paolo Rossetti, et al.
Diabetes Care|February 17, 2007
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetesFrancesca Porcellati, Paolo Rossetti, Natalia Busciantella Ricci, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 2, 2019
Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503]R C Bonadonna, A Giaccari, R Buzzetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2019
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and populationR C Bonadonna, A Giaccari, R Buzzetti, et al.
Diabetes|November 1, 1993
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDMC G Fanelli, L Epifano, A M Rambotti, et al.
Diabetes|November 25, 2003
Insulin is required for prandial ghrelin suppression in humansGiuseppe Murdolo, Paola Lucidi, Chiara Di Loreto, et al.
Clinical Endocrinology|September 21, 2006
The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical studyC Di Cosmo, G Fanelli, M Tonacchera, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Diabetes|July 27, 2001
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemiaS A Segel, C G Fanelli, C S Dence, et al.
Diabetes/Metabolism Research and Reviews|March 3, 2020
Comparable efficacy with similarly low risk of hypoglycaemia in patient- vs physician-managed basal insulin initiation and titration in insulin-naïve type 2 diabetic subjects: The Italian Titration Approach StudyRiccardo C Bonadonna, Andrea Giaccari, Raffaella Buzzetti, et al.
Diabetes Care|October 23, 2012
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetesPaola Lucidi, Francesca Porcellati, Paolo Rossetti, et al.
Diabetes Care|April 19, 2011
Pharmacokinetics and pharmacodynamics of therapeutic doses of basal insulins NPH, glargine, and detemir after 1 week of daily administration at bedtime in type 2 diabetic subjects: a randomized cross-over studyPaola Lucidi, Francesca Porcellati, Paolo Rossetti, et al.
Diabetes Care|February 17, 2007
Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetesFrancesca Porcellati, Paolo Rossetti, Natalia Busciantella Ricci, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 2, 2019
Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503]R C Bonadonna, A Giaccari, R Buzzetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2019
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and populationR C Bonadonna, A Giaccari, R Buzzetti, et al.
Diabetes|November 1, 1993
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDMC G Fanelli, L Epifano, A M Rambotti, et al.
Diabetes|November 25, 2003
Insulin is required for prandial ghrelin suppression in humansGiuseppe Murdolo, Paola Lucidi, Chiara Di Loreto, et al.
Clinical Endocrinology|September 21, 2006
The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical studyC Di Cosmo, G Fanelli, M Tonacchera, et al.
Pageof 22